Trial
NCT01205828
ABT-888 and Temozolomide for Liver Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Georgetown University
Collaborators
Abbott
Condition
Hepatocellular Carcinoma
Intervention
Temozolomide
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-12